LAURA WOOLEY: Open Payments
NPI 1982148011 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,143 in 50 payments from 15 companies in 2025. Trend: 2023 $515 · 2024 $1,360 · 2025 $1,143
Food & beverage: $1,071Education: $72
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $175 |
| UCB, Inc. | 8 | $170 |
| Regeneron Healthcare Solutions, Inc. | 5 | $148 |
| GENZYME CORPORATION | 4 | $118 |
| Novartis Pharmaceuticals Corporation | 3 | $82 |
| SANOFI-AVENTIS U.S. LLC | 1 | $72 |
| E.R. Squibb & Sons, L.L.C. | 2 | $69 |
| ABBVIE INC. | 4 | $64 |
| LEO Pharma Inc. | 3 | $51 |
| Galderma Laboratories, L.P. | 3 | $49 |
Products named: DUPIXENT, OTEZLA, Bimzelx, COSENTYX, Sotyktu, SKYRIZI, NEMLUVIO, ADBRY.
Industry payments across NV — which companies pay providers there.
